NCT06122389
- Conditions
- Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
- Locations
-
- Peking University Cancer Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Explore clinical trials studying Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy. Study availability and eligibility vary by location and protocol.
NCT06122389